| Latest Dor Biopharma News Headlines | | Date | Time | Source | | | 09/15/2005 | 4:41PM | PRNUS | Dr. Chris Dale, Vice President, Technology, Cambrex Biopharmaceuticals and Dr. Robert N. Brey, Chief Scientific Officer, DOR Bio
EAST RUTHERFORD, N.J. and MIAMI, Sept. 15 /PRNewswire-FirstCall/ -- Cambrex Corporation (NYSE:CBM) and DOR BioPharma, Inc. (AMEX:DOR) are pleased to announce that Chris Dale, Ph.D., Vice President, Technology, Cambrex Biopharmaceuticals business and Robert N. Brey, Ph.D., Chief Scientific Officer, DOR BioPharma will... More...>> |
| 07/26/2005 | 12:07PM | PRNUS | DOR BioPharma and Dowpharma Enter Into a Joint Development Agreement for BT-VACC(TM), DOR's Oral Vaccine Against Botulinum Toxin
DOR BioPharma and Dowpharma Enter Into a Joint Development
Agreement for BT-VACC(TM), DOR's Oral Vaccine Against Botulinum Toxin Poisoning
MIAMI, July 26 /PRNewswire-FirstCall/ -- DOR BioPharma, Inc. (AMEX:DOR)
("DOR", or the "Company") today announced it has entered into a joint
development agreement with Dowpharma(SM... More...>> |
| 01/07/2005 | 8:30AM | PRNUS | DOR BioPharma and Cambrex Enter into a Development and Manufacturing Process Agreement for RiVax(TM)
DOR BioPharma and Cambrex Enter into a Development and
Manufacturing Process Agreement for RiVax(TM)
MIAMI and EAST RUTHERFORD, N.J., Jan. 7 /PRNewswire-FirstCall/ -- DOR
BioPharma, Inc. (AMEX:DOR) and a subsidiary of Cambrex Corporation (NYSE:CBM)
have entered into an agreement with respect to process development for
potential... More...>> |
|